A systematic review on hydroxyurea therapy for sickle cell disease in India

A systematic review on hydroxyurea therapy for sickle cell disease in India

Background & objectives: Sickle cell disease (SCD) constitutes frequently inherited haemoglobin disorders and poses a significant health burden in India. Hydroxyurea (HU), the most commonly used drug, has shown promising results in the clinical management of SCD. The present systematic review wa...

Full description

Bibliographic Details
Main Authors: Apoorva Pandey, Harpreet Kaur, Sapan Borah, Naveen Khargekar, Vijay Kumar Karra, Tulsi Adhikari, Dipty Jain, Manisha Madkaikar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Medical Research
Subjects:
foetal haemoglobin - haemoglobinopathies - hospitalization - hydroxyurea - sickle cell disease - vaso-occlusive crisis
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2022;volume=156;issue=2;spage=299;epage=311;aulast=Pandey

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2022;volume=156;issue=2;spage=299;epage=311;aulast=Pandey

Similar Items